IPO

With its massive data library and AI platforms, Tempus AI prepares for a pivotal presentation. What will CEO Eric Lefkofsky reveal to investors?

Silver Oak Securities launches AFX Custom Models, giving independent advisors access to elite portfolios from top asset managers to streamline operations and grow.

Lazard Asset Management creates a new CIO role, appointing Eric Van Nostrand to unify its global investment platform amid fierce industry competition.

STAAR Surgical stockholders rejected a lucrative Alcon merger, betting on the standalone potential of their EVO ICL lenses despite recent financial headwinds.

SUI Group's appointment of former CFTC Commissioner Brian Quintenz signals a strategic push for regulatory credibility and institutional crypto adoption.

Forrester names NICE Actimize a leader in APAC fraud solutions, citing its advanced AI as crucial for securing the region's booming digital economy.

MSC Income Fund nets a massive return on a logistics firm, then reinvests in a merger creating a direct mail powerhouse. Here’s what it means for investors.

A major gold strike next to Nevada's famed Getchell Trend and the appointment of a renowned mine-finder signal a pivotal new chapter for Eminent Gold.

Main Street Capital realizes a massive gain from its Mystic Logistics exit and reinvests to merge it with UBM, creating a powerhouse in marketing mail.

Processa Pharmaceuticals completes enrollment for a pivotal analysis of its NGC-Cap therapy, offering new hope for a safer, more effective cancer treatment.

With a $257M war chest and a veteran team, BlossomHill will showcase its innovative pipeline for lung cancer and leukemia at the pivotal JPM conference.

With stunning clinical data for its miv-cel therapy, Kyverna is set to outline a new era for autoimmune treatment at the J.P. Morgan conference.

As the private equity market rebounds, Evercore hires a seasoned banker to strengthen its financial sponsors group, signaling a major strategic play.

With blockbuster sales from VYJUVEK, Krystal Biotech heads to J.P. Morgan with investors eager for news on its global growth and ambitious pipeline.

Off The Hook's new luxury division leverages AI and an integrated model to secure ~$100M in listings and close 22 deals in its explosive first quarter.

Vantage Corp finalizes its PJ Marine Singapore acquisition, a strategic move into China's lucrative market despite recent financial headwinds.

AMC Robotics establishes a new manufacturing hub in Ho Chi Minh City, a strategic move to scale its Kyro robot and join the global tech shift to Vietnam.

With promising 3-year vision data and a manufacturing breakthrough, Lineage is pioneering 'off-the-shelf' cell therapies for blindness, diabetes, and more.

Formerly Cybin, Helus Pharma's Nasdaq launch marks a pivotal shift towards commercializing its breakthrough depression and anxiety drug pipeline.

EMERGE Commerce CEO Ghassan Halazon unveils a new strategy, detailing past growth errors and a multi-year turnaround that pivots the firm to disciplined growth.